Business Description
Farabi Pharmaceutical
ISIN : IRO1DFRB0008
Description
Farabi Pharmaceutical is a pharmaceutical company based in Iran. It produces various oral antibiotic-related and non-antibiotic products and dietary supplements. The company develops anti-migraine, antivirals, cholesterol, diabetic, cardiovascular, gastrointestinal, neuroleptics, anti-prostatic and anti-inflammatory and pain release drugs. It offers products in the form of tablet, capsule and suspensions which include Amoxicillin, Cefixime, Azithromycin, Ciprofloxacin, Nitroglycerin, Repaglinide, Orlistat, Domperidone, among others.
Financial Strength
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
6-1 Month Momentum % | 37.09 | |||||
12-1 Month Momentum % | -28.22 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 9.66 | |||||
5-Year Yield-on-Cost % | 9.66 |
Profitability Rank
| Name | Current | Vs Industry | Vs History |
|---|
GF Value Rank
| Name | Current | Vs Industry | Vs History |
|---|
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Farabi Pharmaceutical Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil IRR) | |||
| EPS (TTM) (IRR) | - | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | 0.51 | ||
| 3-Year Sortino Ratio | 1.19 | ||
| Volatility % | 26.7 | ||
| 14-Day RSI | - | ||
| 14-Day ATR (IRR) | 346.428571 | ||
| 20-Day SMA (IRR) | - | ||
| 12-1 Month Momentum % | -28.22 | ||
| 52-Week Range (IRR) | 10210 - 22500 | ||
| Shares Outstanding (Mil) |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Farabi Pharmaceutical Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Farabi Pharmaceutical Stock Events
| Event | Date | Price (IRR) | ||
|---|---|---|---|---|
| IRR 5375.000000 Cash Dividend | 2025-05-21 | -- |
Show
Entries
Farabi Pharmaceutical Frequently Asked Questions
What is Farabi Pharmaceutical(XTEH:DFRB1)'s stock price today?
The current price of XTEH:DFRB1 is IRR10500.00. The 52 week high of XTEH:DFRB1 is IRR22500.00 and 52 week low is IRR10210.00.
When is next earnings date of Farabi Pharmaceutical(XTEH:DFRB1)?
The next earnings date of Farabi Pharmaceutical(XTEH:DFRB1) is .
Does Farabi Pharmaceutical(XTEH:DFRB1) pay dividends? If so, how much?
The Dividend Yield %  of Farabi Pharmaceutical(XTEH:DFRB1) is 9.66% (As of Today), Highest Dividend Payout Ratio of Farabi Pharmaceutical(XTEH:DFRB1) was 0. The lowest was 0. And the median was 0. The  Forward Dividend Yield % of Farabi Pharmaceutical(XTEH:DFRB1) is 0%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Farabi Pharmaceutical
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers